BIOMAT Database Logo BIOMAT Database Logo

Mdm2, but not Mdm4, protects terminally differentiated smooth muscle cells from p53-mediated caspase-3-independent cell death. 2006

L S M Boesten, and S M Zadelaar, and S De Clercq, and S Francoz, and A van Nieuwkoop, and E A L Biessen, and F Hofmann, and S Feil, and R Feil, and A G Jochemsen, and C Zurcher, and L M Havekes, and B J M van Vlijmen, and J-C Marine
Department of General Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands.

p53 is a potent inhibitor of cell growth and an inducer of apoptosis. During embryonic development, Mdm2 and Mdm4 inhibit the growth suppressive activities of p53. However, whether tight surveillance of p53 activity is required in quiescent cells is unknown. To test this, conditional inactivation of mdm2 and mdm4 was carried out in smooth muscle cells (SMCs). Upon SMC-specific inactivation of mdm2, and not of mdm4, mice rapidly became ill and died. Necropsy showed small intestinal dilation, and histological analyses indicated a severe reduction in the number of intestinal SMCs. Increased p53 levels and activity were detected in the remaining SMCs, and the phenotype was completely rescued on a p53-null background. Interestingly, intestinal SMCs are caspase-3-negative and therefore did not undergo caspase-3-dependent apoptotic cell death. Together, Mdm2, but not Mdm4, prevents accumulation of active p53 in quiescent SMCs and thereby the induction of p53-mediated caspase-3-independent cell death.

UI MeSH Term Description Entries
D007421 Intestine, Small The portion of the GASTROINTESTINAL TRACT between the PYLORUS of the STOMACH and the ILEOCECAL VALVE of the LARGE INTESTINE. It is divisible into three portions: the DUODENUM, the JEJUNUM, and the ILEUM. Small Intestine,Intestines, Small,Small Intestines
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016159 Tumor Suppressor Protein p53 Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER. p53 Tumor Suppressor Protein,Cellular Tumor Antigen p53,Oncoprotein p53,TP53 Protein,TRP53 Protein,p53 Antigen,pp53 Phosphoprotein,Phosphoprotein, pp53
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D044767 Ubiquitin-Protein Ligases A diverse class of enzymes that interact with UBIQUITIN-CONJUGATING ENZYMES and ubiquitination-specific protein substrates. Each member of this enzyme group has its own distinct specificity for a substrate and ubiquitin-conjugating enzyme. Ubiquitin-protein ligases exist as both monomeric proteins multiprotein complexes. Ubiquitin-Protein Ligase,E3 Ligase,E3 Ubiquitin Ligase,Ubiquitin Ligase E3,Ubiquitin-Protein Ligase E3,Ligase E3, Ubiquitin,Ligase E3, Ubiquitin-Protein,Ligase, E3,Ligase, E3 Ubiquitin,Ligase, Ubiquitin-Protein,Ligases, Ubiquitin-Protein,Ubiquitin Ligase, E3,Ubiquitin Protein Ligase,Ubiquitin Protein Ligase E3,Ubiquitin Protein Ligases
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

L S M Boesten, and S M Zadelaar, and S De Clercq, and S Francoz, and A van Nieuwkoop, and E A L Biessen, and F Hofmann, and S Feil, and R Feil, and A G Jochemsen, and C Zurcher, and L M Havekes, and B J M van Vlijmen, and J-C Marine
P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death.
February 1999, Blood,
L S M Boesten, and S M Zadelaar, and S De Clercq, and S Francoz, and A van Nieuwkoop, and E A L Biessen, and F Hofmann, and S Feil, and R Feil, and A G Jochemsen, and C Zurcher, and L M Havekes, and B J M van Vlijmen, and J-C Marine
MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation.
March 2017, Oncogene,
L S M Boesten, and S M Zadelaar, and S De Clercq, and S Francoz, and A van Nieuwkoop, and E A L Biessen, and F Hofmann, and S Feil, and R Feil, and A G Jochemsen, and C Zurcher, and L M Havekes, and B J M van Vlijmen, and J-C Marine
Mdm2 Splice isoforms regulate the p53/Mdm2/Mdm4 regulatory circuit via RING domain-mediated ubiquitination of p53 and Mdm4.
April 2017, Cell cycle (Georgetown, Tex.),
L S M Boesten, and S M Zadelaar, and S De Clercq, and S Francoz, and A van Nieuwkoop, and E A L Biessen, and F Hofmann, and S Feil, and R Feil, and A G Jochemsen, and C Zurcher, and L M Havekes, and B J M van Vlijmen, and J-C Marine
MdmX protects p53 from Mdm2-mediated degradation.
February 2000, Molecular and cellular biology,
L S M Boesten, and S M Zadelaar, and S De Clercq, and S Francoz, and A van Nieuwkoop, and E A L Biessen, and F Hofmann, and S Feil, and R Feil, and A G Jochemsen, and C Zurcher, and L M Havekes, and B J M van Vlijmen, and J-C Marine
A novel antioxidant-inhibited dexamethasone-mediated and caspase-3-independent muscle cell death.
December 2003, Annals of the New York Academy of Sciences,
L S M Boesten, and S M Zadelaar, and S De Clercq, and S Francoz, and A van Nieuwkoop, and E A L Biessen, and F Hofmann, and S Feil, and R Feil, and A G Jochemsen, and C Zurcher, and L M Havekes, and B J M van Vlijmen, and J-C Marine
Mitochondrial p53 phosphorylation induces Bak-mediated and caspase-independent cell death.
July 2015, Oncotarget,
L S M Boesten, and S M Zadelaar, and S De Clercq, and S Francoz, and A van Nieuwkoop, and E A L Biessen, and F Hofmann, and S Feil, and R Feil, and A G Jochemsen, and C Zurcher, and L M Havekes, and B J M van Vlijmen, and J-C Marine
Deficiency of caspase-3 in MCF7 cells blocks Bax-mediated nuclear fragmentation but not cell death.
May 2001, Clinical cancer research : an official journal of the American Association for Cancer Research,
L S M Boesten, and S M Zadelaar, and S De Clercq, and S Francoz, and A van Nieuwkoop, and E A L Biessen, and F Hofmann, and S Feil, and R Feil, and A G Jochemsen, and C Zurcher, and L M Havekes, and B J M van Vlijmen, and J-C Marine
Macrophage-mediated clearance of cells undergoing caspase-3-independent death.
March 2003, Cell death and differentiation,
L S M Boesten, and S M Zadelaar, and S De Clercq, and S Francoz, and A van Nieuwkoop, and E A L Biessen, and F Hofmann, and S Feil, and R Feil, and A G Jochemsen, and C Zurcher, and L M Havekes, and B J M van Vlijmen, and J-C Marine
p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53.
March 1999, Oncogene,
L S M Boesten, and S M Zadelaar, and S De Clercq, and S Francoz, and A van Nieuwkoop, and E A L Biessen, and F Hofmann, and S Feil, and R Feil, and A G Jochemsen, and C Zurcher, and L M Havekes, and B J M van Vlijmen, and J-C Marine
Nerve growth factor withdrawal-mediated apoptosis in naive and differentiated PC12 cells through p53/caspase-3-dependent and -independent pathways.
April 2004, The Journal of biological chemistry,
Copied contents to your clipboard!